Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS Linical Aims to Become “One-Stop” CRO for Global Clinical Trials
August 8, 2014
-
BUSINESS Daiwa Corporate Investment Establishes Venture Capital Firm Specializing in Biopharmaceuticals; Sights Set on Seeds of University Origin
August 7, 2014
-
REGULATORY MHLW to Survey Rate of Generic Drug Use Under High-Cost Healthcare System; Regulatory Reform Council Concerned that System Provides Little Incentive to Use Generics
August 6, 2014
-
ACADEMIA JSH to Adopt Tougher COI Rule after Panel Said Novartis’s Involvement in SIGN Trial Should Have Been Disclosed at Conference
August 5, 2014
-
BUSINESS Development of Antibody Drugs Accelerating in the Field of Asthma; First New Option Could Be Available as Early as 2016
August 5, 2014
-
REGULATORY MHLW to Fund Research Aimed at Obtaining Additional Indications for Intractable and Orphan Diseases for Existing Drugs
August 4, 2014
-
REGULATORY PAFSC First Committee Backs Approval of MSD’s Insomnia Treatment
August 4, 2014
-
REGULATORY Improvement Order Issued to Novartis over Delayed ADR Reporting
August 1, 2014
-
BUSINESS Nissan Chemical Files Livalo Patent Suit against Sawai in US
July 31, 2014
-
REGULATORY Regulatory Review Trend in Japan Signals Pharmas’ Shift to Cancer Drugs: Jiho Tally
July 30, 2014
-
REGULATORY NIBIO Initiates Support for Applied Research on 15 Promising Drug Seeds with Goal of First Licensing Agreement by FY2015
July 30, 2014
-
REGULATORY MHLW to Review Criteria for Clinical Research Core Hospitals by April
July 29, 2014
-
BUSINESS AbbVie Hopes to Make Humira Major Drug for Biologics-Naïve Patients: President
July 28, 2014
-
ORGANIZATION JPMA President Hints at Adoption of Unified System to Disclose Fees Paid to Doctors Next Year
July 25, 2014
-
BUSINESS Ono, BMS Announce Strategic Alliance for 5 Immuno-Oncology Products
July 25, 2014
-
BUSINESS Astellas Gears Up to Accelerate R&D
July 24, 2014
-
REGULATORY Chain Pharmacies’ Drug Price Settlement Rate in June Triples from 2 Years Ago
July 23, 2014
-
BUSINESS Disclosure of Payments from Drug Makers to Doctors Delayed
July 22, 2014
-
BUSINESS Carna Shooting for 1st Licensing Deal on Kinase Inhibitor in 2014
July 18, 2014
-
BUSINESS Merck Serono Japan Hopes to Boost Erbitux Share by Narrowing Down CRC Patients: President
July 17, 2014
ページ
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Recent trends are creating a fascinating push-and-pull effect in the talent market. We’re seeing more positions opening up, but also a greater number of candidates available, particularly in the fields of rare diseases and oncology. This “more positions, more candidates”…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…